Upregulation of , , and as Prognostic Biomarkers in Thyroid Cancer: A Pan-Cancer and TCGA Data Analysis.
1/5 보강
The study of gene anomalies linked to thyroid cancer is gaining more and more attention, and these molecular indicators can offer scholarly support for thyroid cancer diagnosis, therapy selection, and
APA
Zhu N, Cai L, Qian L (2025). Upregulation of , , and as Prognostic Biomarkers in Thyroid Cancer: A Pan-Cancer and TCGA Data Analysis.. International journal of molecular sciences, 26(8). https://doi.org/10.3390/ijms26083887
MLA
Zhu N, et al.. "Upregulation of , , and as Prognostic Biomarkers in Thyroid Cancer: A Pan-Cancer and TCGA Data Analysis.." International journal of molecular sciences, vol. 26, no. 8, 2025.
PMID
40332815 ↗
Abstract 한글 요약
The study of gene anomalies linked to thyroid cancer is gaining more and more attention, and these molecular indicators can offer scholarly support for thyroid cancer diagnosis, therapy selection, and prognosis. Genotype-tissue expression pan-cancer data and The Cancer Genome Atlas (TCGA) were used to investigate the expression of , , and . In order to assess the relationship between , , and expression and patient outcome, TCGA clinical survival data were used. We used the clusterProfiler R software tool to conduct enrichment analysis of , , and . Moreover, TCGA database analysis was used to assess the relationship between immune cell infiltration and , , and expression. , , and were strongly expressed in several kinds of malignancies including thyroid cancer. Gene sets related to proliferation that are involved in leukocyte cell-cell adhesion and mononuclear cell differentiation were significantly correlated with high expression of , , and . Additional investigation revealed a correlation between high T cell and DC (dendritic cell) infiltration scores and high expression of , , and . According to our research, , , and could all be genes associated with thyroid cancer.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (3)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.